2025-08-20 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical (ISRG) based on the data provided.

**Intuitive Surgical Inc (ISRG) Analysis**

**0. Executive Summary:**

This report analyzes Intuitive Surgical Inc. (ISRG), a company focused on robotic surgical systems. The analysis includes a review of its stock performance relative to the S&P 500 (VOO), recent price movements, market risk indicators, recent news, and earnings/financial data.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company Description:** Intuitive Surgical Inc. develops, manufactures, and markets robotic surgical systems.
*   **ISRG Cumulative Return:** 113.37%
*   **VOO Cumulative Return:** 100.85%
*   **Dispersion:**
    *   Max: 56.6
    *   Min: -25.5
    *   Current: -24.1
    *   Relative Dispersion: 1.7

**Analysis:** ISRG has outperformed the S&P 500 over the period in question, as indicated by its higher cumulative return. However, the current dispersion is near the minimum observed, suggesting a recent period of underperformance relative to the benchmark. The relative dispersion of 1.7 indicates that ISRG's current underperformance falls within the lower range of its historical volatility compared to the S&P 500.

**Alpha, Beta, and Financial Metrics:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 39.0% | 0.0 | 43.4 |
| 2016-2018  | 77.0% | 63.4% | 59.0% | 0.0 | 57.0 |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3 | 70.3 |
| 2018-2020  | 47.0% | 63.4% | 28.0% | 0.2 | 97.3 |
| 2019-2021  | 91.0% | 63.0% | 43.0% | 0.2 | 128.2 |
| 2020-2022  | -3.0% | 69.9% | -6.0% | 0.2 | 94.7 |
| 2021-2023  | -5.0% | 72.9% | -23.0% | 0.9 | 120.4 |
| 2022-2024  | 26.0% | 72.9% | 0.0% | 0.9 | 186.3 |
| 2023-2025  | 34.0% | 72.9% | -19.0% | 0.6 | 171.8 |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate demonstrates strong performance in earlier periods (2017-2019) but a recent slowdown with negative returns in 2020-2022 and 2021-2023. Recent growth (2022-2025) looks to be recovering
*   **MDD:** The Maximum Drawdown indicates significant downside risk, consistently high across all periods.
*   **Alpha:** The Alpha value, representing excess return relative to the benchmark, is generally positive in earlier periods but turns negative more recently, indicating underperformance.
*   **Beta:** The Beta value is consistently low (around 0.2) until the more recent period, then sharply rises, suggesting that the stock is now more sensitive to market movements than in the past.
*   **Cap:** Market capitalization has generally increased over time, reflecting the company's overall growth, but has slightly pulled back in the most recent period.

**2. Recent Price Action**

*   **Closing Price:** 481.28
*   **Last Market Data:** Price: 479.2, Previous Close: 481.28, Change: -0.43
*   **5-Day Moving Average:** 479.83
*   **20-Day Moving Average:** 484.91
*   **60-Day Moving Average:** 515.62

**Analysis:**

The current price is below the 5-day and 20-day moving averages, which are themselves below the 60-day moving average. This suggests a short-term downtrend in the stock price. The last market data shows a slight negative change (-0.43), reinforcing the recent downward momentum.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.329 (Low Risk)
*   **RSI:** 37.20
*   **PPO:** 0.27
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (8 shares - Safe - MRI:0.33)
*   **20-Day Relative Dispersion Change:** -3.3 (Negative Trend)
*   **Expected Return:** 300.8% (Long-Term, vs. S&P 500)

**Analysis:**

*   **MRI:** The low-risk MRI suggests relatively stable market conditions for ISRG.
*   **RSI:** The RSI of 37.20 indicates that the stock is approaching oversold conditions, which might suggest a potential buying opportunity.
*   **PPO:** The positive PPO suggests a short-term upward trend in price momentum.
*   **Hybrid Signal:** Recommends buying the stock (high allocation), which is likely influenced by the low MRI and potential oversold RSI.
*   **Relative Dispersion Change:** The negative change in relative dispersion confirms the recent underperformance relative to the S&P 500.
*   **Expected Return:** The high expected return suggests significant potential for long-term outperformance.
*   **Last Market Price:** The slight negative change in the last market price is a minor factor, but consistent with other indicators of short-term downward momentum.

**4. Recent News & Significant Events**

*   **[2025-08-18]:** Intuitive Surgical Inc (ISRG) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-08-19]:** Analysts are discussing Intuitive Surgical Inc's (ISRG) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-08-20]:** Intuitive Surgical Inc (ISRG)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-17]:** Market experts highlight both risks and opportunities for Intuitive Surgical Inc (ISRG), advising investors to monitor recent news and company announcements.

**Analysis:**

The news indicates that ISRG has been subject to recent scrutiny due to market events, regulatory changes, and analyst discussions. The stock has shown volatility due to recent news, earnings reports, or executive actions.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-07-23 | 1.84 | 2.44 B$    |
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2025-07-23 | 1.48 | 2.01 B$    |

**Analysis:**

The trend in EPS (Earnings Per Share) is upward, with 1.95 in 2025-04-23, but recently declined slightly to 1.84. Similarly, revenue has been increasing, indicating the company's growth.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $2.44B    | 66.31%        |
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-06-30   | $17.85B   | 3.69% |
| 2025-03-31   | $17.11B   | 4.08% |
| 2024-12-31   | $16.43B   | 4.17% |
| 2024-09-30   | $15.58B   | 3.63% |
| 2024-06-30   | $14.71B   | 3.58% |

**Analysis:**

*   **Revenue and Profitability:** Revenue shows a positive trend, with recent quarters indicating growth. Profit margins remain consistently high, suggesting strong operational efficiency.
*   **Capital and Profitability:** Equity has been steadily increasing, indicating a healthy accumulation of assets. ROE (Return on Equity) fluctuates, but overall, profitability remains solid.

**7. Overall Assessment & Recommendations**

*   **Summary:** ISRG has historically outperformed the S&P 500, but recent data suggests short-term underperformance. The stock is approaching oversold conditions. Recent news suggests volatility is influenced by market events and regulatory changes. Financials show strong revenue and high-profit margins. The expected return is high (long-term), but the recent underperformance needs consideration.
*   **Recommendation:** Given the high expected return and oversold RSI, the hybrid signal recommends a buy. However, the recent negative trend and volatility should be closely monitored. Consider allocating a portion of cash (as per the hybrid signal) and monitoring news and earnings reports to make informed investment decisions. Conduct further research on the "major business developments, regulatory changes, or market events" mentioned in recent news to understand their potential impact.
